Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-26-000330

Chief Financial Officer disposed of 1,314 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Carter Robert Ross · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-17 Other disposition : show line 1 in the form −1,314 $3.59 $4,717 233,811 D
Loading xslF345X06/ownership.xml…